• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液腺癌的化疗

Chemotherapy for salivary gland cancer.

作者信息

Suen J Y, Johns M E

出版信息

Laryngoscope. 1982 Mar;92(3):235-9. doi: 10.1288/00005537-198203000-00003.

DOI:10.1288/00005537-198203000-00003
PMID:6279995
Abstract

Salivary gland cancers are usually treated with surgery and irradiation; however, some of the aggressive salivary gland cancers recur or metastasize and are not amendable to treatment with further surgery or irradiation. Little is known about chemotherapy for these palliative situations because of the relatively scarcity of these cancers. The data in the literature has provided little clinical information because all salivary gland cancers are usually lumped together and/or multiple different drug combination are used. In an effort to arrive at a rational basis for recommending specific drug regimens for specific histologic types of salivary gland cancers, a two-part study was undertaken to determine which chemotherapy drugs seem to be effective or ineffective. One part was a literature review, and the second part was a survey of numerous institutions' experiences, including our own. A total of 85 cases of salivary gland cancers treated with chemotherapy were felt to be evaluable for this study. The overall response rate (complete and partial) was 42%. Although disease responded whether it was local, regional, or distant disease, there was a higher response rate in local-regional disease compared to distant metastases. Salivary gland cancers are definitely sensitive to chemotherapy drugs. This study reveals which drugs seem to be effective and provides some rational basis for future chemotherapy trials for salivary gland cancers.

摘要

唾液腺癌通常采用手术和放疗进行治疗;然而,一些侵袭性唾液腺癌会复发或转移,无法通过进一步手术或放疗进行治疗。由于这类癌症相对较少,对于这些姑息治疗情况的化疗了解甚少。文献中的数据提供的临床信息很少,因为所有唾液腺癌通常被归为一类,并且/或者使用了多种不同的药物组合。为了为推荐针对特定组织学类型唾液腺癌的特定药物方案找到合理依据,开展了一项分为两部分的研究,以确定哪些化疗药物似乎有效或无效。一部分是文献综述,第二部分是对众多机构(包括我们自己的机构)经验的调查。本研究共纳入了85例接受化疗的唾液腺癌病例。总体缓解率(完全缓解和部分缓解)为42%。尽管无论是局部、区域还是远处疾病都有反应,但与远处转移相比,局部-区域疾病的缓解率更高。唾液腺癌对化疗药物肯定敏感。这项研究揭示了哪些药物似乎有效,并为未来唾液腺癌的化疗试验提供了一些合理依据。

相似文献

1
Chemotherapy for salivary gland cancer.唾液腺癌的化疗
Laryngoscope. 1982 Mar;92(3):235-9. doi: 10.1288/00005537-198203000-00003.
2
Chemotherapy for salivary gland cancer.
Otolaryngol Head Neck Surg. 1986 Sep;95(2):165-70. doi: 10.1177/019459988609500206.
3
Systemic therapy in the palliative management of advanced salivary gland cancers.晚期唾液腺癌姑息治疗中的全身治疗
J Clin Oncol. 2006 Jun 10;24(17):2673-8. doi: 10.1200/JCO.2005.05.3025.
4
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).尼达尼布治疗复发性或转移性头颈部唾液腺癌患者的临床试验:一项多中心2期研究(韩国癌症研究组HN14-01)。
Cancer. 2017 Jun 1;123(11):1958-1964. doi: 10.1002/cncr.30537. Epub 2017 Jan 19.
5
Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.涎腺腺样囊性癌:化疗与分子治疗综述
Oral Oncol. 2006 Sep;42(8):759-69. doi: 10.1016/j.oraloncology.2006.01.001. Epub 2006 Jun 6.
6
Systemic therapy in the management of metastatic or advanced salivary gland cancers.转移性或晚期唾液腺癌的系统治疗。
Oral Oncol. 2012 Oct;48(10):948-957. doi: 10.1016/j.oraloncology.2012.05.004. Epub 2012 Jun 12.
7
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.系统治疗在唾液腺腺样囊性癌转移或局部复发中的应用:一项系统评价。
Lancet Oncol. 2011 Aug;12(8):815-24. doi: 10.1016/S1470-2045(10)70245-X. Epub 2010 Dec 10.
8
Chemotherapy of malignant major salivary gland neoplasms: a 25-year review of M. D. Anderson Hospital experience.恶性大唾液腺肿瘤的化疗:对MD安德森医院25年经验的回顾
Cancer. 1977 Aug;40(2):619-24. doi: 10.1002/1097-0142(197708)40:2<619::aid-cncr2820400205>3.0.co;2-e.
9
Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.环磷酰胺、阿霉素和顺铂用于晚期唾液腺癌治疗
B-ENT. 2011;7(1):1-6.
10
An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents.恶性唾液腺癌全身治疗的最新进展:化疗和分子靶向药物的作用
Curr Med Chem Anticancer Agents. 2004 Nov;4(6):543-51. doi: 10.2174/1568011043352641.

引用本文的文献

1
Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances.腺样囊性癌:分子特征与治疗进展的见解
MedComm (2020). 2024 Sep 11;5(9):e734. doi: 10.1002/mco2.734. eCollection 2024 Sep.
2
Image-guided volumetric modulated arc therapy (IG-VMAT) for unresectable ACC of the trachea: a feasible curative option.影像引导容积调强弧形放疗(IG-VMAT)用于不可切除的气管腺样囊性癌:一种可行的治愈性选择。
BMJ Case Rep. 2019 Mar 21;12(3):e227128. doi: 10.1136/bcr-2018-227128.
3
Systemic therapy in the management of metastatic or advanced salivary gland cancers.
转移性或晚期唾液腺癌治疗中的全身治疗
Head Neck Oncol. 2012 May 4;4:19. doi: 10.1186/1758-3284-4-19.
4
Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature.化疗在涎腺肿瘤姑息治疗中的活性:文献综述
Eur Arch Otorhinolaryngol. 2007 Jun;264(6):587-94. doi: 10.1007/s00405-007-0297-x. Epub 2007 Apr 6.
5
Adenoid cystic carcinoma of the skull base.颅底腺样囊性癌
Skull Base Surg. 1999;9(4):271-5. doi: 10.1055/s-2008-1058137.
6
Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.动脉内减瘤化疗治疗泪腺腺样囊性癌效果的临床及显微切割基因分型分析
Trans Am Ophthalmol Soc. 2005;103:337-67.
7
Current role of chemotherapy in exclusive and integrated treatment of malignant tumours of salivary glands.化疗在唾液腺恶性肿瘤单纯治疗与综合治疗中的当前作用。
Acta Otorhinolaryngol Ital. 2005 Jun;25(3):179-81.
8
Chemotherapy for cranial base tumors.
J Neurooncol. 1994;20(3):327-35. doi: 10.1007/BF01053047.
9
[Malignant tumors of the salivary glands: early diagnosis, follow-up and therapy].[唾液腺恶性肿瘤:早期诊断、随访与治疗]
Arch Otorhinolaryngol. 1983 Apr;237(3):227-41. doi: 10.1007/BF00453728.
10
Methotrexate and 5-fluorouracil in the treatment of squamous and other carcinomas of the head and neck.
Cancer Chemother Pharmacol. 1986;17(1):91-4. doi: 10.1007/BF00299874.